Bone Metastasis Prognostic Factors in Breast Cancer

被引:29
作者
Yazdani, Akram [1 ]
Dorri, Sara [2 ]
Atashi, Alireza [3 ]
Shirafkan, Hoda [1 ]
Zabolinezhad, Hedieh [4 ]
机构
[1] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Sch Publ Hlth, Tehran, Iran
[2] ACECR, Motamed Canc Inst, Breast Canc Res Ctr, Med Informat Dept, Tehran, Iran
[3] Univ Tehran Med Sci, Virtual Sch, E Hlth Dept, 2 Dolatshahi Alley,Naderi ST,Keshavarz Blvd, Tehran 1416614741, Iran
[4] Mashhad Univ Med Sci, Imam Reza Hosp, Informat Technol Ctr, Mashhad, Iran
来源
BREAST CANCER-BASIC AND CLINICAL RESEARCH | 2019年 / 13卷
关键词
bone metastases; breast cancer; prognostic factor; CLINICAL-COURSE; RISK-FACTORS; SCINTIGRAPHY; HEMOGLOBIN; PATTERN;
D O I
10.1177/1178223419830978
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Bone is the most common site of metastasis in breast cancer. Prognostic factors for predicting bone metastases in breast cancer are controversial yet. In this study, we investigated clinical factors associated with secondary bone metastasis of breast cancer. Methods: In total, 1690 patients with breast cancer recorded between 2002 and 2012 in Motamed Cancer Institute, Tehran, Iran entered in the retrospective study. We studied age, menopausal status, histologic type, tumor size, number of cancerous axillary lymph nodes, serum concentrations of alkaline phosphatase (ALP), carcinogenicity antigen (CEA), cancer antigen (CA)-153, and hemoglobin (HB) in 2 groups with bone metastases (n = 123) and without it, respectively. We applied logistic regression to identify bone metastasis prognostic factors in breast cancer patients and calculated the cut-off value, sensitivity, and characteristics of independent prognostic factors using receiver operating characteristic (ROC) curve analysis. Results : Menopause, larger tumor size, and the greater number of cancerous axillary lymph nodes increased the chance of bone metastases significantly (P<.05). There was no significant difference between mean groups with and without bone metastases regarding serum concentration of CEA, CA-153, HB, and histopathologic type (P>.05). Logistic regression showed that age (odds ratio (OR) = 1.021), menopausal status (OR = 1.854), number of cancerous axillary lymph nodes (OR = 1.065), a tumor size between 2 and 5 cm diameter (OR = 2.002) and more than 5 cm diameter (OR = 4.009), and ALP (OR = 1.005) are independent prognostic factors associated with bone metastases. The ROC curve showed that the above mentioned factors have comparable predictive accuracy for bone metastases. Conclusions: Age, menopausal status, number of axillary lymph node metastases, tumor size, and ALP were identified as prognostic factors for bone metastasis in patients with breast cancer. So patients with these characteristics should be monitored more precisely with regular follow-ups.
引用
收藏
页数:7
相关论文
共 27 条
  • [1] Bisphosphonates, bone, and breast cancer recurrence
    Brufsky, Adam
    Mathew, Aju
    [J]. LANCET, 2015, 386 (10001) : 1319 - 1320
  • [2] Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer
    Chen, Wen-Zhao
    Shen, Jun-Feng
    Zhou, Yang
    Chen, Xuan-Yin
    Liu, Jia-Ming
    Liu, Zhi-Li
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [3] THE CLINICAL COURSE OF BONE METASTASES FROM BREAST-CANCER
    COLEMAN, RE
    RUBENS, RD
    [J]. BRITISH JOURNAL OF CANCER, 1987, 55 (01) : 61 - 66
  • [4] Metastatic bone disease: clinical features, pathophysiology and treatment strategies
    Coleman, RE
    [J]. CANCER TREATMENT REVIEWS, 2001, 27 (03) : 165 - 176
  • [5] Clinical course and prognostic factors following bone recurrence from breast cancer
    Coleman, RE
    Smith, P
    Rubens, RD
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (02) : 336 - 340
  • [6] Identifying breast cancer patients at high risk for bone metastases
    Colleoni, M
    O'Neill, A
    Goldhirsch, A
    Gelber, RD
    Bonetti, M
    Thürlimann, B
    Price, KN
    Castiglione-Gertsch, M
    Coates, AS
    Lindtner, J
    Collins, J
    Senn, HJ
    Cavalli, F
    Forbes, J
    Gudgeon, A
    Simoncini, E
    Cortes-Funes, H
    Veronesi, A
    Fey, M
    Rudenstam, CM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) : 3925 - 3935
  • [7] The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer
    Cook, Gary J. R.
    Venkitaraman, Ram
    Sohaib, Aslam S.
    Lewington, Valerie J.
    Chua, Sue C.
    Huddart, Robert A.
    Parker, Christopher C.
    Dearnaley, David D.
    Horwich, Alan
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (01) : 7 - 13
  • [8] Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma
    Delpech, Yann
    Bashour, Sami I.
    Lousquy, Ruben
    Rouzier, Roman
    Hess, Kenneth
    Coutant, Charles
    Barranger, Emmanuel
    Esteva, Francisco J.
    Ueno, Noato T.
    Pusztai, Lajos
    Ibrahim, Nuhad K.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 113 (07) : 1003 - 1009
  • [9] Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
    Diessner, Joachim
    Wischnewsky, Manfred
    Stueber, Tanja
    Stein, Roland
    Krockenberger, Mathias
    Haeusler, Sebastian
    Janni, Wolfgang
    Kreienberg, Rolf
    Blettner, Maria
    Schwentner, Lukas
    Woeckel, Achim
    Bartmann, Catharina
    [J]. BMC CANCER, 2016, 16
  • [10] Tumor markers in the diagnosis of primary bladder cancer. A systematic review
    Glas, AS
    Roos, D
    Deutekom, M
    Zwinderman, AH
    Bossuyt, PMM
    Kurth, KH
    [J]. JOURNAL OF UROLOGY, 2003, 169 (06) : 1975 - 1982